Rockwell Medical, Inc.
RMTI
$1.22
$0.010.83%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -534.99% | 12.48% | 50.00% | 188.89% | 110.38% |
| Total Depreciation and Amortization | 2.55% | -1.10% | -1.27% | -3.72% | 222.94% |
| Total Amortization of Deferred Charges | 193.33% | -59.82% | -89.29% | -4.35% | -67.39% |
| Total Other Non-Cash Items | 26.09% | 47.92% | 64.55% | -28.88% | -15.60% |
| Change in Net Operating Assets | 1,047.62% | -71.23% | 100.98% | 120.29% | -140.82% |
| Cash from Operations | 27.88% | -46.51% | 2,111.63% | 213.91% | 182.87% |
| Capital Expenditure | 42.66% | 54.68% | -818.60% | -1,093.75% | -257.50% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -96.95% | -- | -96.93% | -383.84% | 12,418.75% |
| Cash from Investing | -106.00% | 99.28% | -116.53% | 40.61% | 2,782.81% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -55.80% | 9.16% | 81.74% | 61.03% | -6.15% |
| Issuance of Common Stock | -- | -- | 244.99% | -73.62% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -1,818.42% | -2,169.77% | -- |
| Cash from Financing | -131.48% | -539.89% | 476.28% | -81.99% | 1,688.46% |
| Foreign Exchange rate Adjustments | -- | -- | -200.00% | 0.00% | -200.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -79.10% | -82.44% | 171.57% | 139.58% | 369.82% |